GOULD CAPITAL, LLC CRISPR Therapeutics AG Transaction History

GOULD CAPITAL, LLC portfolio value:

$6,000
portfolio value

GOULD CAPITAL, LLC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 1K $65.35 90
Q2 2022 share 0.00% 0 shares -1K $60.77 90
Q1 2022 share 0.00% 0 shares -1K $62.77 90
Q4 2021 share Increase 0.00% 90 shares 7K $78.85 90